Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss Perspective

14 Aug 2019

Abstract excerpt

In Switzerland, 2.3% of pregnant women develop preeclampsia. Quantification of the soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF) ratio has shown a diagnostic value in the second and third trimesters of pregnancy, in particular in ruling out preeclampsia within one week. We estimated the economic impact of implementing sFlt-1/PlGF ratio evaluation, in addition to the standard of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Birth, Development, and Health
Share to Pregnancy and preeclampsia studies
Share to Reproductive System and Pregnancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31485276
DOI: 10.1155/2019/4096847

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

sFlt-1/PlGF Ratio as a Predictive Marker in Women with Suspected Preeclampsia: An Economic Evaluation from a Swiss PerspectivePMID 31485276Read ↗

Diagnostic accuracy of sFlt1/PlGF ratio as a marker for preeclampsiaSemantic proximity Read ↗

The sFlt-1:PlGF Ratio in Women with Suspected PreeclampsiaSemantic proximity Read ↗

Biomarkers and the Prediction of Adverse Outcomes in PreeclampsiaSemantic proximity Read ↗

Prognostic value of angiogenic markers in pregnancy with fetal growth restrictionSemantic proximity Read ↗

A Review of the Diagnosis, Risk Factors, and Role of Angiogenetic Factors in Hypertensive Disorders of PregnancySemantic proximity Read ↗

Soluble Fms-like tyrosine kinase-1 to placental growth factor ratio in mid-pregnancy as a predictor of preterm preeclampsia in asymptomatic pregnant womenSemantic proximity Read ↗

The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trialSemantic proximity Read ↗

Clinical tools and biomarkers to predict preeclampsiaSemantic proximity Read ↗

Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGFSemantic proximity Read ↗

Glycosylated fibronectin as a biomarker for preeclampsia and preeclampsia-related complicationsSemantic proximity Read ↗

Reference Range Determination for the sFlt-1/PlGF Ratio in a Diverse Cohort of Pregnant Women in the United StatesSemantic proximity Read ↗

Angiogenic growth factors in the diagnosis and prediction of pre-eclampsiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.